Shenzhen Lifotronic Technology Co., Ltd. (688389.SS)
CNY 15.22
(0.33%)
CNY 15.22
(0.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 533.75 Million CNY | 41.57% |
| 2022 | 377.01 Million CNY | 74.14% |
| 2021 | 216.5 Million CNY | 48.31% |
| 2020 | 145.98 Million CNY | 12.91% |
| 2019 | 129.29 Million CNY | -9.92% |
| 2018 | 143.53 Million CNY | 16.56% |
| 2017 | 123.14 Million CNY | -2.8% |
| 2016 | 126.69 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 550.1 Million CNY | 23.85% |
| 2024 Q1 | 444.17 Million CNY | -16.78% |
| 2024 Q3 | 873.75 Million CNY | 58.83% |
| 2023 Q4 | 533.75 Million CNY | 12.14% |
| 2023 Q1 | 383.88 Million CNY | 1.82% |
| 2023 FY | 533.75 Million CNY | 41.57% |
| 2023 Q2 | 493.38 Million CNY | 28.52% |
| 2023 Q3 | 475.99 Million CNY | -3.52% |
| 2022 FY | 377.01 Million CNY | 74.14% |
| 2022 Q4 | 377.01 Million CNY | -3.48% |
| 2022 Q3 | 390.6 Million CNY | 20.26% |
| 2022 Q2 | 324.79 Million CNY | 79.91% |
| 2022 Q1 | 180.53 Million CNY | -16.61% |
| 2021 Q1 | 129.57 Million CNY | -11.24% |
| 2021 Q2 | 196.09 Million CNY | 51.34% |
| 2021 Q3 | 187.56 Million CNY | -4.35% |
| 2021 FY | 216.5 Million CNY | 48.31% |
| 2021 Q4 | 216.5 Million CNY | 15.43% |
| 2020 Q4 | 145.98 Million CNY | 19.46% |
| 2020 Q1 | 125.11 Million CNY | -3.23% |
| 2020 FY | 145.98 Million CNY | 12.91% |
| 2020 Q2 | 141.04 Million CNY | 12.73% |
| 2020 Q3 | 122.19 Million CNY | -13.36% |
| 2019 Q2 | 128.14 Million CNY | 0.0% |
| 2019 FY | 129.29 Million CNY | -9.92% |
| 2019 Q3 | 117.77 Million CNY | -8.09% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 Q4 | 129.29 Million CNY | 9.78% |
| 2018 FY | 143.53 Million CNY | 16.56% |
| 2018 Q4 | 143.53 Million CNY | 0.0% |
| 2017 FY | 123.14 Million CNY | -2.8% |
| 2016 FY | 126.69 Million CNY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Chison Medical Technologies Co., Ltd. | 153.41 Million CNY | -247.907% |